Sarkana Pharma Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants (NCT05156034) | Sarkana Pharma Inc | 2021-12-21 |
Track Sarkana Pharma Inc automatically
Every clearance here is in the API, with alerts when new ones post.